CN Bio Alternatives & Competitors
12 companies similar to CN Bio — Generate human-specific efficacy and safety data with PhysioMimix® microphysiol...
Companies similar to CN Bio
MIMETAS
Human Tissue Models for Better Therapies
The Netherlands
Emulate, Inc.
Our Organ-on-a-Chip technology provides a high-fidelity window into the inner workings of...
Boston, United States
-logo.jpg "Newcells Biotech (Axol Bioscience)"){kind=logo}
Newcells Biotech (Axol Bioscience)
The Newcells ophthalmology business was acquired by Axol Bioscience
Newcastle Upon Tyne, Unit...
River BioMedics
River BioMedics paves the way to the future of cardiac drug discovery
Enschede, The Netherlands
Rival Readout
Competing with CN Bio? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
NeuCyte
Decoding CNS Drug Discovery with SynFire® iP
Mountain View, United Sta...
Cayman Chemical
Helping Make Research Possible
Ann Arbor, United States
InterAx Biotech Ltd
Translating Complex Biology into Breakthrough Medicines
Schlieren, Switzerland
Cellecta, Inc.
Gene Functional Analysis. Simplified.
Mountain View, United Sta...
Moonwalk Biosciences
Pioneering novel therapeutics in adipose biology and tissue, driven by deep genetic and ep...
South San Francisco, Unit...
About CN Bio
CN Bio, founded in 2008 and headquartered in the United Kingdom, is a pioneering player in the Biopharma and Biotechnology sectors, specializing in cutting-edge organ-on-a-chip technology. Their flagship offering, the PhysioMimix® microphysiological systems, is designed to enhance the precision and speed of preclinical...
Organ-on-a-chip models, Non-Alcoholic Steatohepatitis studies, Drug-Induced Liver Injury studies, Custom study design for research goals, Multi-chip plates and consumables, Contract research services
Pharmaceutical companies, Biotechnology researchers, Laboratories focusing on drug efficacy, Safety and ADME departments in healthcare
Organ-on-a-Chip, Microphysiological Systems, Preclinical Drug Discovery, Safety Toxicology, 3D Cell Culture, Primary Human Cells, Human-Specific Efficacy Data, Disease Modeling, Drug-Induced Liver Injury, Pharmaceutical And Biotech Research, Non-Alcoholic Steatohepatitis, Hepatitis B Disease Model, Precision Biology, Microfluidic Cell Culture, Viral Lifecycle Models
B2B, D2C, SaaS
Product Sales, Service Fee, Licensing
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around CN Bio: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at CN Bio on 11 Mar 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 6 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
